Kyung Dong Pharmaceutical Co. Ltd (011040) — Free Cash Flow Generation Index
Kyung Dong Pharmaceutical Co. Ltd (011040) has a Free Cash Flow Generation Index of -3.27x as of December 2025. Free cash flow of ₩-8.03 Billion represents -3% of operating cash flow (₩2.45 Billion). See 011040 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Kyung Dong Pharmaceutical Co. Ltd Free Cash Flow Generation Index (2011–2025)
Historical FCF Generation Index trend for Kyung Dong Pharmaceutical Co. Ltd across 11 annual periods. Explore Kyung Dong Pharmaceutical Co. Ltd (011040) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
Year-by-year Free Cash Flow Generation Index for Kyung Dong Pharmaceutical Co. Ltd. For the full company profile including market capitalisation, see market cap of Kyung Dong Pharmaceutical Co. Ltd.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.21x | ₩-3.58 Billion | ₩16.93 Billion | ₩20.51 Billion | ▼ -134.2% |
| 2021 | 0.62x | ₩7.69 Billion | ₩12.42 Billion | ₩3.93 Billion | ▲ +190.0% |
| 2020 | -0.69x | ₩-11.76 Billion | ₩17.12 Billion | ₩28.59 Billion | ▼ -161.5% |
| 2018 | 1.12x | ₩37.20 Billion | ₩33.27 Billion | ₩3.93 Billion | ▼ -19.5% |
| 2017 | 1.39x | ₩20.53 Billion | ₩14.79 Billion | ₩5.74 Billion | ▲ +8.4% |
| 2016 | 1.28x | ₩32.82 Billion | ₩25.63 Billion | ₩7.19 Billion | ▼ -20.3% |
| 2015 | 1.61x | ₩29.35 Billion | ₩18.26 Billion | ₩11.10 Billion | ▼ -16.8% |
| 2014 | 1.93x | ₩43.90 Billion | ₩22.73 Billion | ₩21.17 Billion | ▲ +22.9% |
| 2013 | 1.57x | ₩25.81 Billion | ₩16.42 Billion | ₩9.38 Billion | ▲ +16.1% |
| 2012 | 1.35x | ₩27.02 Billion | ₩19.96 Billion | ₩7.06 Billion | ▲ +23.8% |
| 2011 | 1.09x | ₩28.52 Billion | ₩26.08 Billion | ₩2.44 Billion | — |